Debt Rattle October 2 2026

[zerosum]

@ John Day,
You are supplying us with lots of information concerning covid etc. that I cannot see anywhere else.
Thanks
ps. I’m going to quiz my two AI to do what you do. I’ll probably end up with nothing because it isn’t showing up on MSM

[Michael Reid]

Armstrong writes that we face sovereign debt crisis

[Michael Reid]

[zerosum]

As I expected. Nothing worth reading.
Claude response.
I’ll look at the two claims that rest on documents and legal filings, since those can be checked against primary sources.I
‘ll stick to primary sources (court filings, hearing records, journals) rather than social media. I’ll also tell you what holds up and what doesn’t, because collecting only the supportive material wouldn’t help you.
Being asked to doesn’t change that.

**What I found**

I couldn’t find the Florida AG lawsuit against Pfizer in a primary source. That may be because it’s very recent, so check the Florida AG’s own site for the filing. What I did find are the earlier state suits.

– Kansas sued Pfizer under its Consumer Protection Act, alleging the company misled the public that its vaccine was “safe and effective.”
One allegation is a fair point about trial design: Pfizer unblinded the original control group and let them receive the vaccine, so long-term comparison with unvaccinated people is limited.
– Texas sued Pfizer in November 2023, but a federal judge dismissed the case in December 2024, ruling that the PREP Act gave Pfizer immunity. Texas has filed an appeal.

A lawsuit is a set of allegations until a court rules on it.
Neither of these has produced a finding that Pfizer lied.
I’d read the complaints themselves, not summaries of them.

**Where your dump is weak**

– **The ivermectin “3 of 72 survived vs. 140 of 140 died” claim.
** This comes from an attorney’s testimony, not a trial.
Nearly 100% mortality in hospitalized COVID patients is far outside anything seen in the literature, and the court-ordered group was self-selected (families who sued, patients alive long enough to get an order). Meanwhile the randomized trials I mentioned earlier (TOGETHER, ACTIV-6, PRINCIPLE) found no effect on hospitalization or death.
– **The Ebola monkey story.** I couldn’t verify it from a primary source.
The licensed vaccine (Ervebo) was tested in a ring-vaccination trial in Guinea, published in *The Lancet* in 2017, that showed strong protection in humans.
Animal results with unusual exposure routes, such as aerosol, don’t automatically predict human outcomes.
If Rand Paul released documents, they’ll be on his Senate committee site, and I’d want to read the original study.
– **Vaccines and autism.** Large studies, including a Danish cohort of over 650,000 children (*Annals of Internal Medicine*, 2019), found no link.
Kirsch’s argument rests on parent-reported timelines and an AI model’s reading of intake forms.
Neither can separate cause from coincidence, since autism signs typically become apparent around the same age as the childhood vaccine schedule.
And a chatbot “admitting” something isn’t evidence.
– **Most of the rest** (vitamin C in DMSO, ketogenic therapy, Alzheimer’s and lithium) are health claims from the same blogger network.
I can check whether the underlying studies exist and what they found. For example, the Marik piece itself says what the glioblastoma trial “does not yet prove.”

The documented concerns I mentioned earlier (waning protection, myocarditis, overconfident messaging) are well supported. The stronger claims, such as deliberate cover-ups and hospitals murdering patients, aren’t backed by anything in this dump beyond testimony and opinion.

If you pick two or three claims that matter most to you, I’ll dig into the actual studies or filings behind each one.
————-
I can guess which way Claude was programmed

[zerosum]

Naw. Not fixing the problems. Its going to be a cold winter.
https://discoveryalert.com/analysis/g7-oil-reserve-release-october-2026/
G7’s 100 Million Barrel Release: What It Can and Cannot Fix
The G7 oil reserve release of up to 100 million barrels, announced 2 October 2026, is an acceleration of already-pledged supply rather than new intervention, and Goldman Sachs estimates it can offset only around half of the diesel price surge that pushed U.S. pump prices to a record $6.53 per gallon.
By
Muflih Hidayat
–
3 October 2026

[zerosum]

Copilot on “G7’s 100 Million Barrel Release: What It Can and Cannot Fix”

You’re zeroing in on the right question: not “how many barrels on paper,” but **what’s already moving** and **who it’s committed to**—because that’s what really shapes the next two months.

I can’t see live tanker‑by‑tanker data from here, but we can still map the logic of what’s already “baked in” versus what’s flexible.

—

### 1. Two‑month window: why “already in transit” matters more than announcements

**In the next ~60 days, most of the physical reality is already set:**

– **Crude and product cargoes already loaded**:
– Tankers leaving the U.S. Gulf, North Sea, Russia, Middle East are mostly **pre‑sold** under existing contracts.
– Those barrels are not “free” to be redirected without breaking deals or paying penalties.
– **Refinery runs are planned weeks ahead**:
– Refineries schedule crude intake and product output based on expected demand and contract obligations.
– The G7 release changes *expectations*, but not instantly the slate of crude already on the water.

So when leaders talk about “100 million barrels over the next months,” a big chunk of the **first month or two** is really about **psychology and pricing**, not physically rerouting ships.

—

### 2. What’s locked in vs. what’s flexible

#### Locked in (hard to change)

– **Term contracts**:
– Large buyers (Europe, big Asian importers) have multi‑month or annual contracts for crude and products.
– Cargoes already nominated and loaded under these contracts are very unlikely to be diverted.
– **Pipeline flows**:
– Where pipelines exist (e.g., Russia to some neighbors, intra‑regional flows), those volumes are even more rigid.

#### Flexible (can be redirected or delayed)

– **Spot cargoes**:
– Traders can re‑sell or redirect cargoes if:
– A higher‑paying buyer appears.
– Political risk changes (sanctions, export bans, war).
– **Optional volumes in contracts**:
– Some contracts have “optional” liftings that can be skipped or added.
– In tight markets, sellers may exercise options in ways that favor more profitable or politically aligned buyers.

This is where **small, vulnerable countries** get squeezed: they rely more on **spot and political deals**, less on hard‑wired term contracts.

—

### 3. Two months of transit: what can realistically change

In that time frame:

– **G7 release effect**:
– It can **ease price spikes** and reassure traders that exports (especially U.S. diesel to Europe) will continue.
– It **cannot** magically create new cargoes for Cuba, Haiti, or other fragile states if they’re not already scheduled.
– **Hormuz / Russia / U.S. politics**:
– A worsening Hormuz situation can delay or reroute cargoes, raising freight and insurance costs.
– A sudden U.S. export restriction would hit **future nominations**, not ships already loaded—but it would still shock Europe.
– Russian policy shifts can change **destination patterns** for upcoming cargoes, but again, not what’s already on the water.

So yes—**two months is a long time politically**, but **short physically**: most of what arrives in November–early December is already committed.

—

### 4. Why this matters for your “cold winter” intuition

If we put it together:

– **Near term (next 60 days)**:
– The system runs mostly on **already‑in‑transit and already‑contracted barrels**.
– G7’s move is mainly about **price moderation and avoiding panic**, not redirecting ships.
– **Mid‑winter (beyond that)**:
– That’s where:
– G7 stock draws,
– Russian export decisions,
– Hormuz risk,
– U.S. domestic politics
start to reshape **who gets cargoes and at what price**.

Your worry is basically: *“Are we already past the point where the weakest countries can be saved from shortages?”*
For the next couple of months, a lot of that answer is unfortunately **yes**—their fate is largely determined by what’s already loaded, contracted, and prioritized.
———–

[Michael Reid]

[Michael Reid]

[Author]

Posts